First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
François Anna, Elodie Bole-Richard, Joel LeMaoult, Marie Escande, Martin Lecomte, Jean-Marie Certoux, Philippe Souque, Francine Garnache, Olivier Adotevi, Pierre Langlade-Demoyen, Maria Loustau, Julien Caumartin
Journal for ImmunoTherapy of Cancer, March 2021
Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC
Ching-Lien Wu, Julien Caumartin, Giada Amodio, François Anna, Maria Loustau, Silvia Gregori, Pierre Langlade-Demoyen, Joel LeMaoult
Frontiers in Immunology, 11 January 2021
HLA-G Neo-Expression on Tumors
Loustau M, Anna F, Dréan R, Lecomte M, Langlade-Demoyen P, Caumartin J.
Frontiers in Immunology 2020
CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm
Bôle-Richard E, Fredon M, Biichlé S, Anna F, Certoux J-M, Renosi F, Tsé F, Molimard C, Valmary-Degano S, Jenvrin A, Warda W, Pallandre J-R, BonnefoyF , Poussard M, Deschamps M, Petrella T, Roumier C, Macintyre E, Féger F, Brissot E, Mohty M, HoWangYin K-Y, Langlade-Demoyen P, Loustau M, Caumartin J, Godet Y, Binda D, Pagadoy M, Deconinck E, Daguindau E, Saas P, Ferrand C, Angelot-Delettre F, Adotévi O, Garnache-Ottou F.
Leukemia, 2020
